Efficacy of docetaxel in disseminated classical Kaposi's sarcoma [31]

British Journal of Dermatology

Volumn 143, Issue 6, 2000, Pages 1357-1359

  Stoebner, P E ^a   Nocera, T ^a   Meynadier, J ^a   Meunier, L ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL;

DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HUMAN; KAPOSI SARCOMA; LETTER; PRIORITY JOURNAL;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; MALE; PACLITAXEL; SARCOMA, KAPOSI; TAXOIDS;

EID: 0034522138     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03941.x     Document Type: Letter

References (11)

1. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel
2. Classic Kaposi sarcoma; epidemiology and risk factors
3. Kaposi's disease
4. Kaposi's sarcoma; advances in tumor biology and pharmacotherapy
5. Classic Kaposi sarcoma; experience at Rabin Medical Center in Israel
6. An aggressive case of classic Kaposi's sarcoma
7. Recent progress in the clinical development of docetaxel (Taxotere)
8. Docetaxel
9. Complete resolution of Kaposi's sarcoma with systemic etretinate therapy in a patient with mycosis fungoides
10. Treatment of AIDS-associated Kaposi's sarcoma with oral tretinoin
11. Kaposi's sarcoma; advances and perspectives